相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIF Prolyl Hydroxylase Inhibitors Prevent Neuronal Death Induced by Mitochondrial Toxins: Therapeutic Implications for Huntington's Disease and Alzheimer's Disease
Zoya Niatsetskaya et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Mutant Huntingtin in Glial Cells Exacerbates Neurological Symptoms of Huntington Disease Mice
Jennifer Bradford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Effect of Short-Term Free Fatty Acids Elevation on Mitochondrial Function in Skeletal Muscle of Healthy Individuals
Alberto O. Chavez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
A DNAJB Chaperone Subfamily with HDAC-Dependent Activities Suppresses Toxic Protein Aggregation
Jurre Hageman et al.
MOLECULAR CELL (2010)
Huntington's disease: tagged for clearance
Dimitri Krainc
NATURE MEDICINE (2010)
Early Increase in Extrasynaptic NMDA Receptor Signaling and Expression Contributes to Phenotype Onset in Huntington's Disease Mice
Austen J. Milnerwood et al.
NEURON (2010)
A nonradioactive dot blot assay for transglutaminase activity
Stephen J. McConoughey et al.
ANALYTICAL BIOCHEMISTRY (2009)
Putting the 'HAT' back on survival signalling: the promises and challenges of HDAC inhibition in the treatment of neurological conditions
Sama F. Sleiman et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Role of Transglutaminase 2 in Liver Injury via Cross-linking and Silencing of Transcription Factor Sp1
Hideki Tatsukawa et al.
GASTROENTEROLOGY (2009)
Impaired PGC-1α function in muscle in Huntington's disease
Rajnish K. Chaturvedi et al.
HUMAN MOLECULAR GENETICS (2009)
In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
Mary Y. Heng et al.
JOURNAL OF NEUROSCIENCE (2009)
Epigenetics and the nervous system: epiphenomenon or missing piece of the neurotherapeutic puzzle?
Rajiv R. Ratan
LANCET NEUROLOGY (2009)
Balance between synaptic versus extrasynaptic NMDA receptor activity influences inclusions and neurotoxicity of mutant huntingtin
Shu-ichi Okamoto et al.
NATURE MEDICINE (2009)
Brain-derived neurotrophic factor in neurodegenerative diseases
Chiara Zuccato et al.
NATURE REVIEWS NEUROLOGY (2009)
HDAC6 is a target for protection and regeneration following injury in the nervous system
Mark A. Rivieccio et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms
Jennifer Bradford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Mitochondria and Huntington's Disease Pathogenesis Insight from Genetic and Chemical Models
Susan E. Browne
MITOCHONDRIA AND OXIDATIVE STRESS IN NEURODEGENERATIVE DISORDERS (2008)
Cardiac expression of the Drosophila Transglutaminase (CG7356) gene is directly controlled by myocyte enhancer factor-2
Jennifer Ikle et al.
DEVELOPMENTAL DYNAMICS (2008)
Increased levels of γ-glutamylamines in Huntington disease CSF
Thomas M. Jeitner et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Huntingtin Modulates Transcription, Occupies Gene Promoters In Vivo, and Binds Directly to DNA in a Polyglutamine-Dependent Manner
Caroline L. Benn et al.
JOURNAL OF NEUROSCIENCE (2008)
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: Restoration by the neuroprotective compound CEP-1347
Paola Conforti et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2008)
Therapeutic application of histone deacetylase inhibitors for central nervous system disorders
Aleksey G. Kazantsev et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Deregulation of HDAC1 by p25/Cdk5 in Neurotoxicity
Dohoon Kim et al.
NEURON (2008)
The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice
Elizabeth A. Thomas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism
Jong-Min Lee et al.
PLOS GENETICS (2007)
RNAi-induced silencing of the plasma membrane Ca2+-ATPase 2 in neuronal cells:: effects on Ca2+ homeostasis and cell viability
Denzyl Fernandes et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders
Giuseppe Battaglia et al.
JOURNAL OF NEUROCHEMISTRY (2007)
ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease
Hoon Ryu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
PGC-1α:: a key regulator of energy metabolism
Huiyun Liang et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2006)
Increased apoptosis, huntingtin inclusions and altered differentiation in muscle cell cultures from Huntington's disease subjects
A. Ciammola et al.
CELL DEATH AND DIFFERENTIATION (2006)
Oxidative damage in Huntington's disease pathogenesis
Susan E. Browne et al.
ANTIOXIDANTS & REDOX SIGNALING (2006)
Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators
Julie St-Pierre et al.
CELL (2006)
Transcriptional repression of PGC-α by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration
Libin Cui et al.
CELL (2006)
Drosophila in the study of neurodegenerative disease
J. Lawrence Marsh et al.
NEURON (2006)
Hypothalamic-endocrine aspects in Huntington's disease
Asa Petersen et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Cleavage at the caspase-6 site is required for neuronal dysfunction and degeneration due to mutant huntingtin
Rona K. Graham et al.
CELL (2006)
The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase
Craig D. C. Bailey et al.
NEUROBIOLOGY OF AGING (2006)
Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase
M Borrell-Pagès et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Decreased association of the transcription factor Sp1 with genes downregulated in Huntington's disease
AS Chen-Plotkin et al.
NEUROBIOLOGY OF DISEASE (2006)
Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells
ZK Mao et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Mitochondrial cyclic AMP response element-binding protein (CREB) mediates mitochondrial gene expression and neuronal survival
J Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease
JM Van Raamsdonk et al.
JOURNAL OF NEUROCHEMISTRY (2005)
HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism
IS Seong et al.
HUMAN MOLECULAR GENETICS (2005)
Use of within-array replicate spots for assessing differential expression in microarray experiments
GK Smyth et al.
BIOINFORMATICS (2005)
Mechanism for the inhibition of transglutaminase 2 by cystamine
TM Jeitner et al.
BIOCHEMICAL PHARMACOLOGY (2005)
Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila
N Agrawal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Mutant huntingtin protein - A substrate for transglutaminase 1, 2, and 3
GM Zainelli et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2005)
Striatal cells from mutant huntingtin knock-in mice are selectively vulnerable to mitochondrial complex II inhibitor-induced cell death through a non-apoptotic pathway
QM Ruan et al.
HUMAN MOLECULAR GENETICS (2004)
Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation
JH Fox et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Defects in adaptive energy metabolism with CNS-Linked hyperactivity in PGC-1α null mice
JD Lin et al.
CELL (2004)
Histone deacetylase inhibitors prevent oxidative neuronal death independent of expanded polyglutamine repeats via an Sp1-dependent pathway
H Ryu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α):: Transcriptional coactivator and metabolic regulator
P Puigserver et al.
ENDOCRINE REVIEWS (2003)
Insoluble TATA-binding protein accumulation in Huntington's disease cortex
WMC van Roon-Mom et al.
MOLECULAR BRAIN RESEARCH (2002)
'Tissue' transglutaminase ablation reduces neuronal death and prolongs survival in a mouse model of Huntington's disease
P Mastroberardino et al.
CELL DEATH AND DIFFERENTIATION (2002)
Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease
AW Dunah et al.
SCIENCE (2002)
Phosphoinositide 3-kinase activity is required for retinoic acid-induced expression and activation of the tissue transglutaminase
MA Antonyak et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Increased sensitivity to N-methyl-D-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease
MM Zeron et al.
NEURON (2002)
Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine
MV Karpuj et al.
NATURE MEDICINE (2002)
Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila
JS Steffan et al.
NATURE (2001)
Mitochondrial genetic control, of assembly and function of complex I in mammalian cells
A Chomyn
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2001)
Conformational changes in the nucleosome followed by the selective accessibility of histone glutamines in the transglutaminase reaction: Effects of ionic strength
E Ballestar et al.
BIOCHEMISTRY (2001)
Dominant phenotypes produced by the HD mutation in STHdhQ111 striatal cells
F Trettel et al.
HUMAN MOLECULAR GENETICS (2000)
Impaired mitochondrial function results in increased tissue transglutaminase activity in situ
M Lesort et al.
JOURNAL OF NEUROCHEMISTRY (2000)
The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
JS Steffan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Sequential serum-dependent activation of CREB and NRF-1 leads to enhanced mitochondrial respiration through the induction of cytochrome c
RP Herzig et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
